Nhật Bản cân nhắc cho phép tiêm kết hợp các vaccine khác nhau

Bộ Y tế Nhật Bản đang cân nhắc khả năng tiêm kết hợp các loại vaccine ngừa COVID-19 khác nhau nhằm giảm bớt quan ngại về nguồn cung và đẩy nhanh chương trình tiêm chủng tại quốc gia này. Chương trình tiêm chủng của Nhật Bản hiện chủ yếu sử dụng vaccine của hãng dược Pfizer và hãng Moderna.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Chi phí xung đột Israel - Iran vượt 11 tỷ USD

Thế giới
(Baothanhhoa.vn) - Theo thông báo của Bộ Tài chính Israel, chi phí từ xung đột giữa Israel và Iran đang gia tăng nhanh chóng, với ước tính chi phí trực tiếp từ xung đột với Iran kể từ cuối tháng 2/2026 đã lên tới khoảng 35 tỷ shekel (tương đương 11,5 tỷ USD).
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh